Quiescent S-phase cells as indicators of extreme physiological conditions in human tumor xenografts

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 4, 1999, Pages 1019-1024

  Zölzer, Friedo ^a   Stüben, Georg ^b   Knühmann, Kai ^b   Streffer, Christian ^a   Sack, Horst ^b  

^a University Clinics   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cell proliferation; Hypoxia; Prognostic factors; Quiescent S phase cells; Tumor micromilieu

Indexed keywords

BROXURIDINE;

ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA CONTENT; DNA SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; OXYGEN TENSION; POLAROGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; BROMODEOXYURIDINE; CELL HYPOXIA; HUMANS; MICE; MICE, NUDE; NEOPLASMS; OXYGEN; POLAROGRAPHY; S PHASE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0344719134     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00294-1     Document Type: Article

References (26)

1. Darzynkiewic Z., Traganos F., Andreef M., Sharpless T., Melamed M.R. Different sensitivity of chromatin to acid denaturation in quiescent and cycling cells as revealed by flow cytometry. J Histochem Cytochem. 27:1979;478-485.
2. Dethlefsen L.A., Bauer K.D., Riley R.M. Analytical cytometric approaches to heterogeneous cell populations in solid tumors A review . Cytometry. 1:1980;89-97.
3. Streffer C., van Beuningen D., Molls M., Zamboglou N. How relevant is the labeling index for cell proliferation? Br J Cancer. 41:1980;205.
4. 2 DNA content. Cell Tissue Kinet. 16:1983;237-246.
5. 2 phase . Cell Tissue Kinet. 17:1984;453-463.
6. Wilson G.D., McNally N.J., Dunphy E., Kärcher H., Pfragner R. The labeling index of human and mouse tumors assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry. 6:1985;641-647.
7. Schutte B., Reynders M.M.J., van Assche C.L.M.V.J., Hupperets P.S.G.J., Bosman F.T., Blijham G.H. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry. Cytometry. 8:1987;372-376.
8. deFazio A., Leary J.A., Hedley D.W., Tattersall M.H.N. Immunohistochemical detection of proliferating cells in vivo. J Histochem Cytochem. 35:1987;571-577.
9. Riccardi A., Danova M., Wilson G., Ucci G., Dörmer P., Mazzini G., Brugnatelli S., Girino M., McNally N.J., Ascari E. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res. 48:1988;6238-6245.
10. Zölzer F., Streffer C., Pelzer T. Induction of quiescent S-phase cells by irradiation and/or hyperthermia. I. Time and dose dependence. Int J Radiat Biol. 63:1993;69-76.
11. Zölzer F, Streffer C. Sensitivity of human melanoma cells to hyperthermia and/or radiation: Independence of intracellular pH. In: Hagen U, Harder D, Jung H, Streffer C, editors. Radiation research 1895-1995. Proceedings of the 10th International Congress of Radiation Research Society, Würzburg 1995, Vol. 2, p. 985-988.
12. Streffer C, Bauch T, Stüben G, Zölzer F, Müller W-U. Predictive assays for individualization of cancer therapy. In: Kogelnik HD, Sedlmayer F, editors. Progress in radio-oncology VI. Proceedings of the 6th International Meeting on Progress in Radio-Oncology. Bologna: Monduzzi Editore, 1998, p. 501-507.
13. Budach W. Wachstumsverzögerung und Tumorheilung nach Bestrahlung experimenteller Tumoren: Einfluß des Tumorstromas, genetischer Faktoren sowie strahlen- und chemotherapeutischer Vorbehandlungen. Habilitationsschrift, Universitätsklinikum Essen; 1994.
14. Stüben G., Stuschke M., Knühmann K., Horsman M.R., Sack H. The effect of combined nicotinamide and carbogen treatments in human tumor xenografts Oxygenation and tumor control studies . Radiother Oncol. 48:1998;143-148.
15. Lartigau E., Lespinasse F., Vitu L., Guichard M. Does the direct measurement of oxygen tension in tumors have any adverse effect? Int J Radiat Oncol Biol Phys. 22:1992;949-951.
16. Stüben G, Thews O, Pöttgen C, Stuschke M, Sack H. Tumor oxygenation during fractionated radiotherapy: Comparison to size matched controls. Acta Oncol. In press.
17. Budach V., Bamberg M., Streffer C., Budach W., Stuschke M., Fabry W. Establishment and characterization of human tumors in nu/nu-mice. Strahlenther Onkol. 165:1989;500-501.
18. Stüben G., Budach W., Schick K.H. A time saving system for irradiation of experimental tumors. Strahlenther Onkol. 170:1994;36-41.
19. Ang K.K., van der Kogel A.J., van der Schueren E. Inhalation anaesthesia in experimental radiotherapy A reliable and time saving system for multifractionation studies in a clinical department . Int J Radiat Oncol Biol Phys. 8:1982;145-148.
20. 2 histography. Int J Radiat Oncol Biol Phys. 19:1990;953-961.
21. 2M-phase cells in human colorectal carcinomas A flow cytometric study with the Ki-67 antibody . Cell Prolif. 28:1995;313-327.
22. Streffer C. Glucose, energy-metabolism and cell proliferation in tumors. Vaupel P. Oxygen transport in tissue XV. 1994;327-333 Plenum Press, New York.
23. Berry R.J., Hall E.J., Cavanagh J. Radiosensitivity and the oxygen effect for mammalian cells cultured in vitro in stationary phase. Br J Radiol. 43:1970;81-90.
24. Spiro I.J., Rice G.C., Durand R.E., Stickler R., Ling C.C. Cell killing, radiosensitivity and cell cycle redistribution induced induced by chronic hypoxia. Int J Radiat Oncol Biol Phys. 10:1984;1275-1280.
25. Shrieve D.C., Harris J.W. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers. Int J Radiat Biol. 48:1985;127-138.
26. Pettersen E.O., Wang H. Radiation-modifying effect of oxygen in synchronized cells pre-treated with acute or prolonged hypoxia. Int J Radiat Biol. 70:1996;319-326.